USANA HEALTH SCIENCES INC reported first quarter ended April 4, 2026 results: revenue $250 million, net income $7.5 million, EPS $0.41. Guidance reaffirmed.
“(NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026. Key Financial Results First Quarter 2026 vs. First Quarter 2025 • Net sales of $250 million versus $250 million. • Net earnings of $7.5 million versus $9.4 million. • Diluted EPS of $0.41 as compared with $0.49. • Adjusted diluted EPS (1) of $0.61 as compared with”
Debt Financings
USANA HEALTH SCIENCES INC amended revolving credit of up to $75 million with Bank of America, N.A. at Term SOFR plus the applicable margin.
“Swingline Lender and Letter of Credit Issuer, and the other lenders party thereto. The Credit Agreement provides for a revolving credit limit for loans to the Company of up to $75 million (the “Credit Facility”). In addition, at the option of the Company, and subject to certain conditions, the Company may request to increase the aggregate commitment under the”
Shareholder Votes
USANA HEALTH SCIENCES INC shareholders approved Advisory approval of executive compensation at the 2024-05-06 meeting.
“USANA shareholders voted to approve, on an advisory basis, executive compensation as set forth below: Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes 16,559,671 414,043 3,249 543,092”
Shareholder Votes
USANA HEALTH SCIENCES INC shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2024 at the 2024-05-06 meeting.
“USANA shareholders voted to ratify the Board’s selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2024 as set forth below: Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes 17,458,617 60,804 634 -”
Shareholder Votes
USANA HEALTH SCIENCES INC shareholders approved Election of eight directors at the 2024-05-06 meeting.
“USANA shareholders voted to elect eight individuals to the Board of Directors for the succeeding year as set forth below: Name Number of Shares For Number of Shares Withheld Number of Shares Abstaining Broker Non-Votes Kevin G. Guest 16,858,545 118,418 - 543,092 Xia Ding 16,639,033 337,930 - 543,092 John T. Fleming 16,620,330 356,633 - 543,092 Gilbert A. Fuller 15,908,052 1,068,911 - 543,092 J. Scott Nixon, CPA 16,615,187 361,776 543,092 Peggie J. Pelosi 16,623,358 353,605 - 543,092 Frederic Winssinger 16,552,853 424,110 - 543,092 Timothy E. Wood, Ph.D. 16,618,063 358,900 - 543,092”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.